Nanocarriers as an emerging platform for cancer therapy

TL;DR: In this paper, the authors discuss using RGD peptide for improving the therapeutic efficacy of Doxorubicin nanomedicine, which is commonly used for the treatment of breast cancer and lymphoma.

TL;DR: A supramolecular hybrid strategy to fabricate a bio-inspired dendritic system as a versatile delivery nanoplatform that largely enhances the gene transfection efficiency of SHDs approximately 50 000-fold as compared to single PDs at the same R/P ratio.

TL;DR: Wang et al. as mentioned in this paper used hyaluronic acid (HA) to get a water-soluble biomaterial (HA-C60) with excellent biocompatibility, and combined with transferrin (Tf) with significant tumor-targeting efficacy and powerful photodynamic therapy capacity.

TL;DR: The hydrogel template method was used to fabricate homogeneous drug-PLGA microparticles of homogeneous size and shape, expected to provide better prediction and reproducibility of the drug release property of a given formulation.

TL;DR: The ability to predict and circumvent drug resistance is likely to improve chemotherapy, and it has become apparent that resistance exists against every effective drug, even the authors' newest agents.

TL;DR: For further successful development of this field, promising trends must be identified and exploited, albeit with a clear understanding of the limitations of these approaches.

TL;DR: Nanotechnology is a multidisciplinary field, which covers a vast and diverse array of devices derived from engineering, biology, physics and chemistry that can provide essential breakthroughs in the fight against cancer.

TL;DR: In vivo studies under magnetic resonance guidance revealed that exposure to low doses of NIR light in solid tumors treated with metal nanoshells reached average maximum temperatures capable of inducing irreversible tissue damage, and found good correlation with histological findings.